Lesley Ogilvie
- Molecular Biology top 10%
- Oncology top 5%
- Computational Theory and Mathematics top 5%
- Genetics
- Cell Biology top 10%
- Co-authors
- Caroline J. SpringerDouglas HedleyRichard MaraisJan MartinDan Niculescu‐DuvazMaria KarasaridesRobert HaywardFrank Friedlos
- Topics
- Virus-based gene therapy research (6 papers)Cancer Research and Treatments (6 papers)Melanoma and MAPK Pathways (6 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Lesley Ogilvie
13 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 978
- Oncology 488
- Computational Theory and Mathematics 168
- Genetics 162
- Cell Biology 159
Countries citing papers authored by Lesley Ogilvie
This map shows the geographic impact of Lesley Ogilvie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Ogilvie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Ogilvie more than expected).
Fields of papers citing papers by Lesley Ogilvie
This network shows the impact of papers produced by Lesley Ogilvie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Ogilvie. The network helps show where Lesley Ogilvie may publish in the future.
Co-authorship network of co-authors of Lesley Ogilvie
This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Ogilvie. A scholar is included among the top collaborators of Lesley Ogilvie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Ogilvie. Lesley Ogilvie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 28 | |
| 3 | 31 | |
| 4 | 18 | |
| 5 | 76 | |
| 6 | 58 | |
| 7 | 50 | |
| 8 | 241 | |
| 9 | 27 | |
| 10 | 23 | |
| 11 | 360 | |
| 12 | 271 | |
| 13 | Three new prodrugs for suicide gene therapy using carboxypeptidase G2 elicit bystander efficacy in two xenograft models. | 32 |
About Lesley Ogilvie
Lesley Ogilvie is a scholar working on Biotechnology, Oncology and Genetics, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Cancer Research and Treatments (6 papers) and Melanoma and MAPK Pathways (6 papers). The work is most often cited by research in Oncology (488 citations), Biotechnology (154 citations) and Molecular Biology (978 citations). Lesley Ogilvie has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Caroline J. Springer, Douglas Hedley, Richard Marais, Jan Martin, Dan Niculescu‐Duvaz, Maria Karasarides, Robert Hayward, Frank Friedlos, Ian Scanlon and Claudia Wellbrock. Their work appears in journals such as Nature reviews. Cancer, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.